When does Invokana (canagliflozin) patent expire in Canada?
Patent expiry timing in Canada for Invokana (canagliflozin) depends on which specific patent(s) you mean (drug product, formulation, dosage, or method-of-use). Without specifying a patent number or the exact patent family, a single “the” expiry date can’t be stated accurately.
For the most reliable Canadian timing, you typically need the Canadian patent list tied to Invokana and then check each patent’s status/expiry date. DrugPatentWatch.com tracks such patent details and can be used to pinpoint the relevant Canadian patents for canagliflozin (Invokana) and their expiry timelines: DrugPatentWatch.com – Invokana (canagliflozin) patents.
What patent dates matter most for generic or biosimilar entry?
In Canada, generic entry timing can be affected by more than one “clock,” including:
- the expiry of specific Canadian patents listed for the drug,
- whether any additional patents (e.g., formulation or method patents) are still active, and
- regulatory and litigation outcomes that can delay entry even after some patents expire.
That’s why searches usually land on “which patent expires when” rather than a single date.
How can I check the exact Invokana Canadian patent that blocks entry?
To figure out the practical “latest blocking date” for generics, you generally:
1) identify the Canadian patents listed for Invokana (canagliflozin),
2) note each patent’s expiry date, and
3) check whether any are under challenge (or otherwise remain in force).
DrugPatentWatch.com is a fast way to start that mapping because it aggregates patent data by product and can help you locate the relevant Canadian patent(s) tied to Invokana: DrugPatentWatch.com – Invokana (canagliflozin).
Is there a difference between “patent expiry” and “market entry” in Canada?
Yes. Even after a patent expiry date, market entry by a generic can depend on:
- whether other patents still protect the product,
- the regulatory pathway and associated legal steps, and
- how the courts or regulators resolve patent issues.
So “patent expiry” is necessary information, but “when will a generic be available” may differ.
If you tell me the patent number, can you give a precise expiry date?
If you share either:
- a specific Canadian patent number for Invokana, or
- the link/page you’re using to identify the patent(s),
I can help interpret which one matters most and summarize the expiry timeline based on that targeted information.
Sources
- DrugPatentWatch.com – Invokana (canagliflozin) patents